AP, D. A., F, G., RM, O., AP, S., & AK, G. (2022). Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients. Cytometry. Part B, Clinical cytometry, 102(4), 312. https://doi.org/10.1002/cyto.b.22040
Chicago Style (17th ed.) CitationAP, De Azambuja, Gevert F, Oliveira RM, Sebastião AP, and Groth AK. "Use of Flow Cytometry and Cytology to Differentiate Breast Implant-associated Anaplastic Large Cell Lymphoma from Reactive Seromas in Brazilian Patients." Cytometry. Part B, Clinical Cytometry 102, no. 4 (2022): 312. https://doi.org/10.1002/cyto.b.22040.
MLA (9th ed.) CitationAP, De Azambuja, et al. "Use of Flow Cytometry and Cytology to Differentiate Breast Implant-associated Anaplastic Large Cell Lymphoma from Reactive Seromas in Brazilian Patients." Cytometry. Part B, Clinical Cytometry, vol. 102, no. 4, 2022, p. 312, https://doi.org/10.1002/cyto.b.22040.